Android app on Google Play

Pacific Biosciences of California (PACB) Misses Q4 EPS by 2c

February 5, 2013 4:09 PM EST Send to a Friend
Get Alerts PACB Hot Sheet
Trade PACB Now!
Join SI Premium – FREE
Pacific Biosciences of California, Inc. (NASDAQ: PACB) reported Q4 EPS of ($0.39), $0.02 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $4.38 million.

For earnings history and earnings-related data on Pacific Biosciences of California, Inc. (PACB) click here.

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment